We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Impact of MDRs on COVID-19 Patients Among Developing Countries
AI summary Read the abstract
This study examined how multi-drug resistant organisms are affecting COVID-19 patients in developing countries, where antibiotic misuse during the pandemic accelerated resistance spread. The analysis found that elevated antibiotic use during the COVID-19 pandemic intensified the clinical burden of drug-resistant infections in resource-limited settings.
: The COVID-19 virus has killed more than 6.3 million people worldwide. The misuse of antibiotics increased during epidemics, leading to the spread of MDRs. Although antibiotic use is increasing in both developed and developing countries, the utility level and abuse are higher in developing countries. This could have negative consequences for the vaccine, especially considering that many developing countries reported the emergence of many resistant microbes even before the pandemic. Infectious diseases, social and cultural pressures, and telemedicine facilities can all contribute to the overuse of antibiotics. The emergence of multidrug resistance is a major concern, especially in developing countries where health services are already inadequate and diagnostic capacity and facilities for disease prevention and control are inadequate. This might be the major cause of the extensive spread of such diseases. Improper waste management and disposal in hospitals and communities make it easy for clean water to leak from the area, causing many diseases and causing many antibiotics. The potential for microplastics to be turned into anti-bacterial products is also of particular concern for low- and middle-income countries. In the present review, we aim to examine the impact of multidrug resistance in ESKAPE infections coupled with healthcare-associated infections and determine their risk of secondary infection in COVID-19 patients in low- and middle-income countries during the COVID-19 epidemic from a multidisciplinary perspective, identify the challenge for developing countries and seek solutions to solve this problem.
More Papers Like This
COVID-19 pandemic and antimicrobial resistance in developing countries
AI summary Read the abstract
This review examined how the COVID-19 pandemic increased antimicrobial drug use and resistance in developing countries, highlighting that improper waste disposal, hospital effluents, and microplastics acting as vectors for antibiotic-resistant organisms compound resistance risks in lower-income settings that already lack diagnostic capacity and infection control infrastructure.
COVID-19 and antimicrobial resistance: A cross-study
AI summary Read the abstract
This review explores how the COVID-19 pandemic accelerated antimicrobial resistance through increased antibiotic use, widespread disinfectant application, and massive volumes of plastic personal protective equipment waste. Researchers found that pandemic-related microplastic pollution creates additional surfaces for resistant bacteria to colonize and exchange resistance genes. The study highlights the intersection of pandemic waste management and the global antibiotic resistance crisis.
A systematic review of sources, occurrence, behavior and risks of global marine antibiotics
AI summary Read the abstract
This systematic review of global marine antibiotic contamination found that sulfamethoxazole is the most frequently detected antibiotic in seawater, sediment, and marine organisms, with the highest concentrations along coastal China. Coexisting contaminants like microplastics may enhance antibiotic impacts and drive antibiotic resistance gene development in marine environments.
Prevalence of pharmaceuticals and personal care products, microplastics and co-infecting microbes in the post-COVID-19 era and its implications on antimicrobial resistance and potential endocrine disruptive effects
AI summary Read the abstract
This review examines how the COVID-19 pandemic increased environmental contamination from pharmaceuticals, personal care products, and microplastics, all of which can promote antibiotic resistance and disrupt hormones. The surge in mask use, sanitizer disposal, and medication contributed to higher levels of these pollutants in waterways. The combination of microplastics with pharmaceutical residues creates a compounding threat where plastics can carry drug-resistant bacteria and hormone-disrupting chemicals into water supplies.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.